Form 483

PETNET Solutions Inc Form 483, 2012-02-07

FDA issued a Form 483 to PETNET Solutions Inc on 2012-02-07 with 7 public-safe observations.

483· Form 483 issued7 observations

PETNET Solutions Inc · Kent, United States · Issued February 7, 2012

Overview

  • 7 public-safe observations are available for this inspection.
  • 7 structured CFR citations are represented.
  • 3 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

7 Feb 2012
21 CFR 212.20(d)

Determination need for investigation

Cited by Barbara J Breithaupt, James S Stuart, Lawrence Y Lee

7 Feb 2012
21 CFR 212.20(e)

Written QA procedures established, followed

Cited by Barbara J Breithaupt, James S Stuart, Lawrence Y Lee

7 Feb 2012
21 CFR 212.30(b)

Not capable of repeatable valid results

Cited by Barbara J Breithaupt, James S Stuart, Lawrence Y Lee

7 Feb 2012
21 CFR 212.50(b)

Master Production and Control Records

Cited by Barbara J Breithaupt, James S Stuart, Lawrence Y Lee

7 Feb 2012
21 CFR 212.50(b)(7)

Complete instructions, procedures, specs

Cited by Barbara J Breithaupt, James S Stuart, Lawrence Y Lee

Inspected site

PSPETNET Solutions IncKent, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 212.20(d)Cited across public-safe Form 483 observations1x
21 CFR 212.20(e)Cited across public-safe Form 483 observations1x
21 CFR 212.30(b)Cited across public-safe Form 483 observations1x
21 CFR 212.50(b)Cited across public-safe Form 483 observations1x
21 CFR 212.50(b)(7)Cited across public-safe Form 483 observations1x
21 CFR 212.60(b)Cited across public-safe Form 483 observations1x
21 CFR 212.60(d)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 7 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere